[Significance of hemostatic and fibrinolytic changes in thrombus formation in cardiovascular diseases].
D000818:Animals; D001095:Arachidonic Acids / Q000502:physiology; D001161:Arteriosclerosis / Q000503:physiopathology; D001778:Blood Coagulation Disorders / Q000503:physiopathology; D001779:Blood Coagulation Factors / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology; D001808:Blood Vessels / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000150:complications* / Q000503:physiopathology; D005342:Fibrinolysis / Q000187:drug effects; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D013927:Thrombosis / Q000209:etiology* / Q000503:physiopathology
D001095:Arachidonic Acids; D001779:Blood Coagulation Factors
Znachenie izmeneniĭ gemostaza i fibrinoliza v tromboobrazovanii pri serdechno-sosudistykh zabolevaniiakh.